Empowered Funds LLC Has $395,000 Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Empowered Funds LLC cut its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 21.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 989 shares of the biotechnology company’s stock after selling 271 shares during the period. Empowered Funds LLC’s holdings in Axon Enterprise were worth $395,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Empirical Finance LLC increased its stake in Axon Enterprise by 9.8% in the third quarter. Empirical Finance LLC now owns 1,038 shares of the biotechnology company’s stock valued at $415,000 after acquiring an additional 93 shares during the period. Signature Estate & Investment Advisors LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $210,000. CIBC Asset Management Inc grew its stake in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the period. OneDigital Investment Advisors LLC raised its holdings in shares of Axon Enterprise by 35.8% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 2,053 shares of the biotechnology company’s stock worth $820,000 after buying an additional 541 shares in the last quarter. Finally, Kapstone Financial Advisors LLC bought a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $227,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $364.02, for a total transaction of $18,201,000.00. Following the transaction, the chief executive officer now owns 2,980,861 shares of the company’s stock, valued at approximately $1,085,093,021.22. This represents a 1.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 260,256 shares of company stock valued at $105,984,120 in the last three months. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Performance

AXON opened at $636.95 on Monday. Axon Enterprise, Inc. has a 52-week low of $224.28 and a 52-week high of $641.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business’s 50-day simple moving average is $463.58 and its 200 day simple moving average is $368.47. The firm has a market capitalization of $48.57 billion, a PE ratio of 164.59, a PEG ratio of 18.89 and a beta of 0.94.

Analyst Ratings Changes

Several research firms have issued reports on AXON. Craig Hallum increased their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Barclays lifted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.